CVS Health Corporation $CVS Shares Sold by Community Bank N.A.

Community Bank N.A. reduced its position in shares of CVS Health Corporation (NYSE:CVS) by 23.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,233 shares of the pharmacy operator’s stock after selling 6,398 shares during the period. Community Bank N.A.’s holdings in CVS Health were worth $1,464,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Bell Investment Advisors Inc raised its position in shares of CVS Health by 119.8% during the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 248 shares in the last quarter. Roxbury Financial LLC raised its position in shares of CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 202 shares in the last quarter. ORG Partners LLC raised its position in shares of CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 377 shares in the last quarter. Saudi Central Bank acquired a new stake in shares of CVS Health during the 1st quarter valued at approximately $34,000. Finally, Livelsberger Financial Advisory acquired a new stake in shares of CVS Health during the 2nd quarter valued at approximately $35,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.22% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on CVS shares. Robert W. Baird upgraded CVS Health from a “neutral” rating to an “outperform” rating and upped their price objective for the stock from $71.00 to $82.00 in a research note on Thursday, August 14th. Zacks Research downgraded CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. UBS Group upgraded CVS Health from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $67.00 to $79.00 in a research note on Monday, August 18th. Morgan Stanley upped their price objective on CVS Health from $80.00 to $82.00 and gave the stock an “overweight” rating in a research note on Friday, August 1st. Finally, Jefferies Financial Group upped their price objective on CVS Health from $74.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, June 30th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $79.80.

CVS Health Trading Up 0.8%

NYSE:CVS opened at $78.50 on Tuesday. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $79.68. The stock has a market cap of $99.56 billion, a price-to-earnings ratio of 21.93, a PEG ratio of 0.86 and a beta of 0.60. The business has a fifty day moving average of $72.63 and a 200-day moving average of $67.75. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The company had revenue of $98.92 billion during the quarter, compared to analysts’ expectations of $94.87 billion. During the same quarter in the prior year, the business posted $1.83 earnings per share. The company’s revenue for the quarter was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.4%. CVS Health’s dividend payout ratio (DPR) is currently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.